GlobalData
GlobalData

Pharma

Security and privacy concerns of telemedicine still need to be addressed, says GlobalData

The adoption of telemedicine has been accelerated significantly in the wake of COVID-19 outbreak. However, despite the increasing usage of the telehealth solutions, this innovation raises the same old questions related to security and privacy concerns, says GlobalData, a leading data and analytics company.   Urte Jakimaviciute, Senior Director of Market Research at GlobalData, comments: “If […]
Read more

COVID-19 vaccine immunity will require a concerted effort, says GlobalData

In order to achieve ‘herd immunity’ to COVID-19, there are estimates that anywhere from 50–90% of the population will need to achieve immunity. This will require a large amount of coordination and rapid deployment of vaccines to the general population, says GlobalData, a leading data and analytics company. Johanna Swanson, Product Manager at GlobalData, comments: […]
Read more

COVID-19 deaths are being underreported, says GlobalData

COVID-19 deaths are most likely being underreported in the US, according to GlobalData, a leading data and analytics company. Excess deaths measure the difference between observed number of deaths and expected number of deaths. GlobalData calculates that there have been approximately 47,000 to 52,000 excess deaths since February 2, 2020. The causes of these excess […]
Read more

Technologies will help but not solve the emerging COVID-19 mental health crisis, says GlobalData

The COVID-19 pandemic presents significant growth opportunities for mental health and wellbeing technologies, however, telemedicine cannot replace in-person visits and these innovations will not resolve the upcoming crisis as it is novel and unprecedented, says GlobalData, a leading data and analytics company. Urte Jakimaviciute, MSc, Senior Director of Market Research, commented: “The pandemic is predicted […]
Read more

GS-441524 could finally get trialed for feline infectious peritonitis in cats

Clinical trial results for Gilead Science’s remdesivir have shown modest improvement in the recovery of moderately ill COVID-19 patients and remdesivir’s success in humans could mean that GS-441524 will finally get trialed for feline infectious peritonitis (FIP) in cats, says GlobalData. Gilead Sciences published preliminary results from another Phase III study of its antiviral drug […]
Read more

Further research on MIS-C can provide insights on how COVID-19 affects immune system, says GlobalData

Some children have developed a severe inflammatory response due to COVID-19 infection that appears similar to Kawasaki disease. Doctors are referring to this response as pediatric multisystem inflammatory syndrome, or multisystem inflammatory syndrome in children (MIS-C). Although severe COVID-19 illness is less frequent in children, with about 3% of confirmed cases in the US in […]
Read more

Taltz’s Nr-axSpA approval not enough to beat Cosentyx in axSpA

Despite receiving Food and Drug Administration (FDA) approval for the treatment of non-radiographic axial spondyloarthritis (nr-axSpA) before Novartis’s Cosentyx (secukinumab), Eli Lilly’s Taltz (ixekizumab) will not overthrow Cosentyx as the premiere anti-interleukin (IL) 17 biologic in the axSpA space. Taltz is forecast to achieve 2028 sales of $239m across the seven major markets (7MM*), whereas […]
Read more

Results from study show oral selexipag for PAH effective and safe in children, says GlobalData

Oral selexipag could improve treatment for the pediatric population based on its convenient administration, better safety and better tolerability profile compared to currently available options according to GlobalData, a leading data and analytics company. Selexipag is the only prostacyclin receptor agonist approved to target the prostacyclin pathway in adults with PAH, and is indicated for […]
Read more

Latin America has not yet reached peak COVID-19 cases, says GlobalData

Latin American countries are showing dangerous trends of increasing COVID-19 cases. Brazil, Peru, Chile, and Mexico are now ranked second, tenth, thirteenth, and fourteenth, respectively, in the number of COVID-19 cases. GlobalData forecasts that these markets have not yet reached peak case numbers. It is likely that the outbreak will continue to worsen in Latin […]
Read more

Machine learning can aid in COVID-19 epidemiology, says GlobalData

As the COVID-19 pandemic continues to evolve across the globe, a large amount of data on its epidemiology has been generated. Finding relationships and predictive factors in this data can be aided by the application of machine learning and neural networks to find complex patterns in the data more efficiently and help predict the future […]
Read more
1 89 90 91 92 93 110